myriad genetics glp-1 receptor agonist weight management diabetes treatments Glucagon-like peptide-1 receptor: mechanisms and advances in therapy The role of GLP1 receptor
Description
In late April 2025, the FDA issued a key update regarding the use of compounded GLP-1 receptor agonists like semaglutide and tirzepatide
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
Does GLP-1 help with Hashimoto's disease
Discover Now!
Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care
